HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SAH-Bcl9

peptide canonical Wnt inhibitor

Also Known As:

stapled peptide derived from the Bcl9 homology domain-2

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Peptide Fragments: 373
    - SAH-Bcl9: 1

Experts

1.	Bird, Gregory H: 1 article (08/2012)
2.	Carrasco, Daniel E: 1 article (08/2012)
3.	Carrasco, Daniel Ruben: 1 article (08/2012)
4.	Fulciniti, Mariateresa: 1 article (08/2012)
5.	Horst, David: 1 article (08/2012)
6.	Kung, Andrew L: 1 article (08/2012)
7.	Lemieux, Madeleine: 1 article (08/2012)
8.	Mani, Mala: 1 article (08/2012)
9.	Munshi, Nikhil C: 1 article (08/2012)
10.	Ryan, Jeremy: 1 article (08/2012)

Related Diseases

1.	Colorectal Neoplasms (Colorectal Cancer) 08/22/2012 - "SAH-BCL9 also suppresses tumor growth, angiogenesis, invasion, and metastasis in mouse xenograft models of Colo320 colorectal carcinoma and INA-6 multiple myeloma. "
2.	Neoplasms (Cancer) 08/22/2012 - "By inhibiting the BCL9-β-catenin interaction and selectively suppressing oncogenic Wnt transcription, SAH-BCL9 may serve as a prototype therapeutic agent for cancers driven by deregulated Wnt signaling." 08/22/2012 - "SAH-BCL9 also suppresses tumor growth, angiogenesis, invasion, and metastasis in mouse xenograft models of Colo320 colorectal carcinoma and INA-6 multiple myeloma. "
3.	Neoplasm Metastasis (Metastasis) 08/22/2012 - "SAH-BCL9 also suppresses tumor growth, angiogenesis, invasion, and metastasis in mouse xenograft models of Colo320 colorectal carcinoma and INA-6 multiple myeloma. "
4.	Multiple Myeloma 08/22/2012 - "SAH-BCL9 also suppresses tumor growth, angiogenesis, invasion, and metastasis in mouse xenograft models of Colo320 colorectal carcinoma and INA-6 multiple myeloma. "